Chebil A, Falfoul Y, Habibi I, Munier F, Schorderet D, El Matri L
Service d'ophtalmologie B, institut Hédi Rais d'ophtalmologie de Tunis, laboratoire de recherche en oculo-génétique (LR14SP01), faculté de médecine de Tunis, boulevard 9-Avril, 1006 Tunis, Tunisie.
Service d'ophtalmologie B, institut Hédi Rais d'ophtalmologie de Tunis, laboratoire de recherche en oculo-génétique (LR14SP01), faculté de médecine de Tunis, boulevard 9-Avril, 1006 Tunis, Tunisie.
J Fr Ophtalmol. 2016 Mar;39(3):277-86. doi: 10.1016/j.jfo.2015.08.013. Epub 2016 Feb 9.
To evaluate the clinical phenotype of ten Tunisian families with non-syndromic retinitis pigmentosa (RP), to characterize genes and mutations causing these conditions, and to elaborate phenotype-genotype correlations.
Descriptive clinical genetic study of 114 individuals, of whom 27 are affected by non-syndromic RP. Ophthalmic examination and various visual tests were performed. DNA was analyzed using single nucleotide polymorphism, microsatellite genotyping and direct sequencing to determine the genes and mutations involved.
We identified seven mutated genes: RPE65, RDH12, USHER 2A, PDE6a, PDE6b, CRB1, and NR2E3. Analysis of phenotype-genotype correlation indicated that some genes were associated with specific phenotypes. In RPE65 mutations, we found early onset dystrophy, nystagmus, keratoconus, white dot deposits in earlier stages and clumped pigment in later stages. The RDH12-associated phenotype (juvenile RP) showed severe and early-onset dystrophy, diffuse spicule pigmentation, macular edema and thickening, and tomographic re-organization of retinal layers. The CRB1 mutation was characterized by preserved para-arteriolar retinal pigment epithelium and no hemeralopia.
RP is clinically and genetically heterogeneous. The two ultimate goals of research are to provide efficient clinical diagnostic of affected gene by phenotype-genotype correlation and to design novel treatment regimens. Our goal is to create a specific chip for our population, and then future research will focus on the identification of the remaining causal genes, the elucidation of the molecular mechanisms of disease in the retina and the development of gene therapy approaches.
评估十个患有非综合征性视网膜色素变性(RP)的突尼斯家庭的临床表型,鉴定导致这些病症的基因和突变,并阐述表型-基因型相关性。
对114名个体进行描述性临床遗传学研究,其中27人患有非综合征性RP。进行眼科检查和各种视力测试。使用单核苷酸多态性、微卫星基因分型和直接测序分析DNA,以确定相关基因和突变。
我们鉴定出七个突变基因:RPE65、RDH12、USH2A、PDE6a、PDE6b、CRB1和NR2E3。表型-基因型相关性分析表明,一些基因与特定表型相关。在RPE65突变中,我们发现早期发病的营养不良、眼球震颤、圆锥角膜、早期白点状沉积物和后期色素团块。与RDH12相关的表型(青少年RP)表现为严重且早期发病的营养不良、弥漫性针状色素沉着、黄斑水肿和增厚,以及视网膜层的断层重组。CRB1突变的特征是视网膜动脉旁色素上皮保存完好且无夜盲。
RP在临床和遗传上具有异质性。研究的两个最终目标是通过表型-基因型相关性对受影响基因进行有效的临床诊断,并设计新的治疗方案。我们的目标是为我们的人群创建一种特定的芯片,然后未来的研究将集中于鉴定其余的致病基因、阐明视网膜疾病的分子机制以及开发基因治疗方法。